HomeNewsBusinessBuy Tata Global Beverage, Divis Labs, Ajanta Pharma, Ujjivan Financial: Mitessh Thakkar
Trending Topics
Sensex Live
Pine Labs Share Price
Tenneco Clean Air India IPO
Groww IPO
Gold Rate

Buy Tata Global Beverage, Divis Labs, Ajanta Pharma, Ujjivan Financial: Mitessh Thakkar

Mitessh Thakkar of miteshthacker.com recommends buying Tata Global Beverage, Divis Labs, Ajanta Pharma and Ujjivan Financial.

November 14, 2017 / 15:53 IST
Story continues below Advertisement
Remove Ad

Your browser doesn't support HTML5 video.

Mitessh Thakkar of miteshthacker.com told CNBC-TV18, "Tata Global Beverage is a buy with a stop loss of Rs 237 for target of Rs 252.

"Divis Labs is a buy with a stop loss of Rs 985 for target of Rs 1070."

Story continues below Advertisement
Remove Ad

"Ajanta Pharma is a buy with a stop loss of Rs 1220 for target of Rs 1262."

"Buy Ujjivan Financial with a stop loss of Rs 385 for target of Rs 400," he added.

Follow Us On: Facebook twitter instagram linkedin telegram youtube
News
Business New Market New Stocks Income Tax Calculator Election Schedule 2024 India News Economy Mutual Funds Personal Finance IPO News Startups New USA Elections New
Features
Gold Rate Today Silver Rate Today Trending News Startups New National News MC Videos MC You Tube
Tools
SIP Calculator 2 SIP Calculator 3 SIP Calculator 1 New SIP Calculator 4
Specials
PowerYourTrade Master Your Money Game Changers
Network 18 Sites
News18 Firstpost CNN News18 CNBC TV18 Forbes History TV18
Personal Finance
Home Loans up to 50 Lakhs Credit Cards Lifetime Free Finance Tracker Fixed Deposits Fixed Deposit Comparison Fixed Income Account Aggregator
Quick Links
About Us New Contact Us Advisory Alert New Advertise with Us New Disclaimer Privacy Policy Cookie Policy Terms & Conditions Careers Financial Terms (Glossary) Analytical & Information Tool New
Download MC Apps:

Copyright © Network18 Media & Investments Limited. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.